In the present study, we have examined the role of HOTTIP as a prognostic factor in early-stage NSCLC patients treated with curative surgery and found that patients with higher levels of HOTTIP had shorter TTR and shorter OS than patients with low levels. This evidence concerns the gene HOTTIP and non-small cell lung carcinoma.